SARMs we can not buy and are not in trials
S-40542: Offers prostate-specific AR blockade with fewer systemic side effects (e.g., no testosterone/LH surge).
Limitations
Both compounds remain preclinical; no human trials reported.
Long-term safety, efficacy, and tissue selectivity in humans unverified.
S-40542: Offers prostate-specific AR blockade with fewer systemic side effects (e.g., no testosterone/LH surge).
Limitations
Both compounds remain preclinical; no human trials reported.
Long-term safety, efficacy, and tissue selectivity in humans unverified.